Phases précoces tumeurs solides
EMBER (J2J-MC-JZLA)
EMBER: A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination With Anticancer Therapies for Patients With ER+ Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers.
Paris
JEAN-YVES PIERGA